Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe University of Texas Health Science Center, Houston

About this trial

The purpose of this study is to assess effects of intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (dlPFC) and dorsomedial prefrontal cortex (dmPFC) compared to sham on electrophysiological indices of reward sensitivity and motivated attention in adults with cocaine use disorder.

Eligibility criteria

Qualifiers

non-treatment-seeking adults

meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for current cocaine use disorder of at least moderate severity (≥ 4 symptoms)

have at least 1 positive urine Benzoylecgonine (BE) specimen (≥ 300 ng/mL) during intake

be able to understand the consent form and provide written informed consent

Disqualifiers

current DSM-5 diagnosis for substance use disorder (of at least moderate severity) other than cocaine, marijuana, or nicotine

in the opinion of the principal investigator (PI), the presence of any medical, neurological, psychiatric, or physical condition, disease, or illness that, may: (a) compromise interfere, limit, effect or reduce the subject's ability to complete the study; or (b) adversely impact the safety of the subject or the integrity of the data

Structured Clinical Interview for DSM-5 (SCID-5)

Columbia Suicide Severity Rating Scale (C-SSRS) Screener - Answers YES to Questions 3, 4, 5, or 6

Trial design

Treatments tested in this trial

  • TMS to dmPFC
  • TMS to dlPFC
  • Sham iTBS

Treatment groups

75 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator